Skip to content

DR LEEN WEYENBERG

Active
Private limited companyfounded 2024active for 2 yearsKoning Albertstraat 70/1, 2547 Lint, BelgiumKBO/BCE: BE 1005.101.132
Summary

DR LEEN WEYENBERG has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €152,653 and a net result of €79,895. Its solvency ranks better than 95% of 20,649 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
6th largest company by equity in Lint, Health and social work sector1 site
Size
≈ €190,000turnover 2025, estimated
Equity
€152,653
Profit
€79,895
Turnover estimated from the gross margin
Financial health
98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 25 days early
Why 98lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 76.42, cash €134,800Equity €152,653 (98.7% of total assets)Size: total assets €154,657Show the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 87% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 98.7% of total assets
Liquidity 100=
short-term debt 1.3% · cash 87.2%
Profitability 100=
return on assets 51.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,148 companies, NACE 86, micro)
Last 24 months 02-2025: 0.3% 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.4 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €14,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 76.42, compared with 23.07 in 2024, above the usual 1.5; short-term debt: 1.3% and cash: 87.2% of total assets), and 1.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 82% on solvency, 95% on liquidity, 80% on profitability and 90% on growth.

The bankruptcy probability was computed on 29-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 76.42, cash €134,800
NBB · annual accounts
lowers risk · Equity €152,653 (98.7% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €154,657
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 06-07-2026, 25 days ahead of the deadline.
NBB · 2 filings
Deviation from the deadline
2025
25 days early
2024
29 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 2 accounts on average 27 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
30-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Liquidity more than triplescurrent ratio 76.42
  3. Equity above €150,000equity €152,653 ▲107%

Key points

  • Positive: Equity rose in 2025from €73,591 to €152,653 ▲ 107% View
  • Positive: Among the best 5% on solvencysector median 63.0% · 20,649 companies 98.7% View
  • One director decidessole director in office 1 View

By topic

Financials

Financial year
2025
Total assets
€154,657
Profit
€79,895
Solvency
98.7%
Total assets▲ 101%
Net result
20242025
Go to Financials

Timeline

Events
5
Since
2024
Next accounts
by 31-07-2027
  1. 02-07-2025Annual accounts filed
  2. 25-01-2024Incorporation
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
General medical practiceNACE 86210
Founded
23-01-2024
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about DR LEEN WEYENBERG

What is the company number of DR LEEN WEYENBERG?
1005.101.132. In Belgium the VAT number is the company number with BE in front: BE 1005.101.132.
Where is DR LEEN WEYENBERG based?
The registered office is at Koning Albertstraat 70/1, 2547 Lint.Company details
What does DR LEEN WEYENBERG do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DR LEEN WEYENBERG?
Private limited company (BV).
When was DR LEEN WEYENBERG founded?
On 23-01-2024.
Is DR LEEN WEYENBERG still active?
Yes, DR LEEN WEYENBERG is an active enterprise in the KBO register.
What is the turnover of DR LEEN WEYENBERG?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is DR LEEN WEYENBERG profitable?
In financial year 2025, DR LEEN WEYENBERG made a profit of €79,895.
Where can I find the annual accounts of DR LEEN WEYENBERG?
DR LEEN WEYENBERG filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR LEEN WEYENBERG due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to DR LEEN WEYENBERG

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.